Genetic mutations affecting human lipoprotein metabolism.
Zannis
V I
VI
Breslow
J L
JL
D000012:Abetalipoproteinemia / Q000235:genetics; D000595:Amino Acid Sequence; D000818:Animals; D016632:Apolipoprotein A-I; D001054:Apolipoproteins A / Q000235:genetics / Q000378:metabolism; D001057:Apolipoproteins E / Q000235:genetics; D001059:Apoproteins / Q000096:biosynthesis / Q000235:genetics*; D002352:Carrier Proteins; D002788:Cholesterol Esters / Q000378:metabolism; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000378:metabolism; D006952:Hyperlipoproteinemia Type III / Q000235:genetics; D006951:Hyperlipoproteinemias / Q000235:genetics*; D007009:Hypolipoproteinemias / Q000235:genetics*; D008049:Lipase / Q000172:deficiency / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism*; D008075:Lipoproteins, HDL; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D051379:Mice; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D016601:RNA-Binding Proteins; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D018110:Receptors, Lipoprotein; D013631:Tangier Disease / Q000378:metabolism
D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D001057:Apolipoproteins E; D001059:Apoproteins; D002352:Carrier Proteins; D002788:Cholesterol Esters; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D016601:RNA-Binding Proteins; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D018110:Receptors, Lipoprotein; C036053:VLDL receptor; C031616:high density lipoprotein receptors; C075197:high density lipoprotein binding protein; D007862:Phosphatidylcholine-Sterol O-Acyltransferase; D008049:Lipase